A detailed history of Intech Investment Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Intech Investment Management LLC holds 1,803 shares of RGEN stock, worth $260,461. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,803
Previous 9,465 80.95%
Holding current value
$260,461
Previous $1.19 Million 77.54%
% of portfolio
0.0%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.79 - $167.35 $917,830 - $1.28 Million
-7,662 Reduced 80.95%
1,803 $268,000
Q2 2024

Aug 12, 2024

BUY
$120.0 - $182.95 $826,920 - $1.26 Million
6,891 Added 267.72%
9,465 $1.19 Million
Q1 2024

May 10, 2024

SELL
$170.78 - $208.42 $512 - $625
-3 Reduced 0.12%
2,574 $473,000
Q4 2023

Oct 18, 2024

BUY
$114.17 - $185.35 $131,866 - $214,079
1,155 Added 81.22%
2,577 $463,000
Q4 2023

Feb 09, 2024

BUY
$114.17 - $185.35 $131,866 - $214,079
1,155 Added 81.22%
2,577 $463,000
Q3 2023

Oct 18, 2024

SELL
$138.78 - $176.51 $58,148 - $73,957
-419 Reduced 22.76%
1,422 $226,000
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $58,148 - $73,957
-419 Reduced 22.76%
1,422 $226,000
Q2 2023

Oct 18, 2024

SELL
$138.42 - $180.31 $329,854 - $429,678
-2,383 Reduced 56.42%
1,841 $260,000
Q2 2023

Aug 09, 2023

SELL
$138.42 - $180.31 $329,854 - $429,678
-2,383 Reduced 56.42%
1,841 $260,000
Q1 2023

Oct 18, 2024

SELL
$154.26 - $198.1 $808,476 - $1.04 Million
-5,241 Reduced 55.37%
4,224 $711,000
Q1 2023

May 10, 2023

BUY
$154.26 - $198.1 $346,467 - $444,932
2,246 Added 113.55%
4,224 $711,000
Q4 2022

Oct 18, 2024

SELL
$162.42 - $220.56 $1.22 Million - $1.65 Million
-7,487 Reduced 79.1%
1,978 $334,000
Q4 2022

Feb 09, 2023

BUY
$162.42 - $220.56 $321,266 - $436,267
1,978 New
1,978 $334,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.